mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.08 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.08 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |